Recursion Pharmaceuticals, Inc.
$RXRX
Public valuation for Recursion Pharmaceuticals, Inc. (RXRX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$3.00
88% Overvalued
Fair Value Estimate
$0
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $7.25
142% higher than current
Key Metrics
Market Cap
$1.6B
Operating Margin
-1985.5%
Revenue Growth
4.0%
Get free watchlist alerts
Join the waitlist for valuation updates on $RXRX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.